NASDAQ: CCEPCoca Cola Europacific Partners PLC Stock
$95.49-0.03 (-0.03%)
Updated Jul 14, 2025
CCEP Price
$95.49
Fair Value Price
$269.37
Market Cap
$44.02B
52 Week Low
$71.49
52 Week High
$97.23
P/E
28.52x
P/B
4.77x
P/S
1.66x
PEG
1.41x
Dividend Yield
2.23%
Revenue
$22.22B
Earnings
$1.50B
Gross Margin
35.3%
Operating Margin
10.8%
Profit Margin
7.1%
Debt to Equity
2.61
Operating Cash Flow
$3B
Beta
0.65
Next Earnings
Aug 6, 2025
Ex-Dividend
N/A
Next Dividend
N/A
CCEP Overview
Coca-Cola Europacific Partners PLC, together with its subsidiaries, produces, distributes, and sells a range of non-alcoholic ready to drink beverages. The company offers flavours, mixers, and energy drinks; soft drinks, waters, enhanced water, and isotonic drinks; and ready-to-drink tea and coffee, juices, and other drinks. It provides its products under the Coca-Cola, Diet Coke, Coca-Cola Zero Sugar, Fanta, Sprite, Monster Energy, Coca-Cola Energy, Relentless, nalu, URGE, BURN, Kuli, REIGN, POWERADE, Appletiser, Schweppes, FINLEY, mezzo mix, Royal Bliss, Lift, Vio SCHORLE, Coca-Cola Signature Mixers, NORDIC MIST, smartwater, Chaudfontaine, AQUARIUS, VILAS del Turbon, BONAQUA, Apollinaris, Krystal, Honest, Costa Coffee, Fuzetea, CHAQWA, NESTEA, Capri-Sun, Oasis, Minute Maid, MER, and Tropico brands. In addition, the company engages in the bottling and other operations. As of March 15, 2022, it served approximately 600 million consumers. The company was formerly known as Coca-Cola European Partners plc and changed its name to Coca-Cola Europacific Partners PLC in May 2021. Coca-Cola Europacific Partners PLC was founded in 1986 and is based in Uxbridge, the United Kingdom.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine CCEP's potential to beat the market
CHold
- Stocks with a Zen Rating of Hold (C) had an average return of +7.53% per year. Learn More
Zen Rating Component Grades
C
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Beverage
Industry Rating
B
CCEP
Ranked#3 of 15
Ranked#3 of 15
Top Ranked Stocks in Industry
| Name / Ticker | Price | Zen Rating |
|---|---|---|
| $23.10 | B | |
| $89.21 | C | |
| $37.89 | C |
Be the first to know about important CCEP news, forecast changes, insider trades & much more!
CCEP News
Overview
Due Diligence Score
–
Industry Average (36)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how CCEP scored across 38 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
CCEP ($95.49) is undervalued by 64.55% relative to our estimate of its Fair Value price of $269.37 based on Discounted Cash Flow (DCF) modelling, but does not have a significant margin of safety
Below Fair Value Valuation
CCEP ($95.49) is significantly undervalued by 64.55% relative to our estimate of its Fair Value price of $269.37 based on Discounted Cash Flow (DCF) modelling, which includes a healthy margin of safety
Significantly Below Fair Value Valuation
CCEP ($95.49) is trading above... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 35 more CCEP due diligence checks available for Premium users.
Valuation
CCEP fair value
Fair Value of CCEP stock based on Discounted Cash Flow (DCF)
Price
$95.49
Fair Value
$269.37
Undervalued by
64.55%
CCEP ($95.49) is undervalued by... subscribe to Premium to read more.
Below Fair Value Valuation
CCEP ($95.49) is significantly undervalued... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
CCEP ($95.49) is trading above... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
CCEP price to earnings (PE)
For valuing profitable companies with steady earnings
Company
28.52x
Industry
24.61x
Market
31.22x
CCEP is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
CCEP is good value based... subscribe to Premium to read more.
P/E vs Market Valuation
CCEP price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
4.77x
Industry
7.01x
CCEP is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
CCEP price to earnings growth (PEG)
For valuing profitable companies with growth potential
CCEP is poor value relative... subscribe to Premium to read more.
PEG Value Valuation
CCEP's financial health
Profit margin
Revenue
$0.0
Net Income
$0.0
Profit Margin
0%
CCEP's Earnings (EBIT) of $2.40B... subscribe to Premium to read more.
Interest Coverage Financials
CCEP's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$32.4B
Liabilities
$23.0B
Debt to equity
2.61
CCEP's short-term liabilities ($8.86B) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
CCEP's long-term liabilities ($15.18B) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
CCEP's debt has increased relative... subscribe to Premium to read more.
Shrinking Debt Financials
CCEP's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
N/A
Investing
N/A
Financing
N/A
CCEP's operating cash flow ($3.33B)... subscribe to Premium to read more.
Debt Coverage Financials
CCEP vs Beverage Stocks
Coca Cola Europacific Partners Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.